BCG vaccination and interpretation of purified protein derivative test results [2]

Archives of Dermatology

Volumn 133, Issue 7, 1997, Pages 916-917

  Li, V W ^a   Joe, E K ^a   Bowers, K ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; ISONIAZID; TUBERCULOSTATIC AGENT;

ADULT; ANTIBIOTIC PROPHYLAXIS; BCG VACCINATION; CASE REPORT; HUMAN; IMMUNOPROPHYLAXIS; INFECTION RISK; LETTER; MALE; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; TUBERCULIN TEST; TUBERCULOSIS; TUBERCULOSIS CONTROL;

EID: 0030876788     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.133.7.916     Document Type: Letter

References (7)